Covid-19 Treatments Market - Global Outlook and Forecast 2021-2027

March 2021 | 92 pages | ID: CB0226A89CC1EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Covid-19 Treatments in Global, including the following market information:

Global Covid-19 Treatments Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Covid-19 Treatments market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Covid-19 Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Covid-19 Treatments Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Covid-19 Treatments Market Segment Percentages, By Type, 2020 (%)

• Tablet
• Injection

China Covid-19 Treatments Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Covid-19 Treatments Market Segment Percentages, By Application, 2020 (%)

• Mild Symptom Patient
• Critically Ill Patient

Global Covid-19 Treatments Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Covid-19 Treatments Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Covid-19 Treatments Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Covid-19 Treatments Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Gilead Sciences
• Merck
• Eli Lilly and Company
• Regeneron Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Covid-19 Treatments Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Covid-19 Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COVID-19 TREATMENTS OVERALL MARKET SIZE

2.1 Global Covid-19 Treatments Market Size: 2021 VS 2027
2.2 Global Covid-19 Treatments Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Covid-19 Treatments Players in Global Market
3.2 Top Global Covid-19 Treatments Companies Ranked by Revenue
3.3 Global Covid-19 Treatments Revenue by Companies
3.4 Top 3 and Top 5 Covid-19 Treatments Companies in Global Market, by Revenue in 2020
3.5 Global Companies Covid-19 Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Covid-19 Treatments Players in Global Market
  3.6.1 List of Global Tier 1 Covid-19 Treatments Companies
  3.6.2 List of Global Tier 2 and Tier 3 Covid-19 Treatments Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Covid-19 Treatments Market Size Markets, 2021 & 2027
  4.1.2 Tablet
  4.1.3 Injection
4.2 By Type - Global Covid-19 Treatments Revenue & Forecasts
  4.2.1 By Type - Global Covid-19 Treatments Revenue, 2016-2021
  4.2.2 By Type - Global Covid-19 Treatments Revenue, 2022-2027
  4.2.3 By Type - Global Covid-19 Treatments Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Covid-19 Treatments Market Size, 2021 & 2027
  5.1.2 Mild Symptom Patient
  5.1.3 Critically Ill Patient
5.2 By Application - Global Covid-19 Treatments Revenue & Forecasts
  5.2.1 By Application - Global Covid-19 Treatments Revenue, 2016-2021
  5.2.2 By Application - Global Covid-19 Treatments Revenue, 2022-2027
  5.2.3 By Application - Global Covid-19 Treatments Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Covid-19 Treatments Market Size, 2021 & 2027
6.2 By Region - Global Covid-19 Treatments Revenue & Forecasts
  6.2.1 By Region - Global Covid-19 Treatments Revenue, 2016-2021
  6.2.2 By Region - Global Covid-19 Treatments Revenue, 2022-2027
  6.2.3 By Region - Global Covid-19 Treatments Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Covid-19 Treatments Revenue, 2016-2027
  6.3.2 US Covid-19 Treatments Market Size, 2016-2027
  6.3.3 Canada Covid-19 Treatments Market Size, 2016-2027
  6.3.4 Mexico Covid-19 Treatments Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Covid-19 Treatments Revenue, 2016-2027
  6.4.2 Germany Covid-19 Treatments Market Size, 2016-2027
  6.4.3 France Covid-19 Treatments Market Size, 2016-2027
  6.4.4 U.K. Covid-19 Treatments Market Size, 2016-2027
  6.4.5 Italy Covid-19 Treatments Market Size, 2016-2027
  6.4.6 Russia Covid-19 Treatments Market Size, 2016-2027
  6.4.7 Nordic Countries Covid-19 Treatments Market Size, 2016-2027
  6.4.8 Benelux Covid-19 Treatments Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Covid-19 Treatments Revenue, 2016-2027
  6.5.2 China Covid-19 Treatments Market Size, 2016-2027
  6.5.3 Japan Covid-19 Treatments Market Size, 2016-2027
  6.5.4 South Korea Covid-19 Treatments Market Size, 2016-2027
  6.5.5 Southeast Asia Covid-19 Treatments Market Size, 2016-2027
  6.5.6 India Covid-19 Treatments Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Covid-19 Treatments Revenue, 2016-2027
  6.6.2 Brazil Covid-19 Treatments Market Size, 2016-2027
  6.6.3 Argentina Covid-19 Treatments Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Covid-19 Treatments Revenue, 2016-2027
  6.7.2 Turkey Covid-19 Treatments Market Size, 2016-2027
  6.7.3 Israel Covid-19 Treatments Market Size, 2016-2027
  6.7.4 Saudi Arabia Covid-19 Treatments Market Size, 2016-2027
  6.7.5 UAE Covid-19 Treatments Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Gilead Sciences
  7.1.1 Gilead Sciences Corporate Summary
  7.1.2 Gilead Sciences Business Overview
  7.1.3 Gilead Sciences Covid-19 Treatments Major Product Offerings
  7.1.4 Gilead Sciences Covid-19 Treatments Revenue in Global (2016-2021)
  7.1.5 Gilead Sciences Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Covid-19 Treatments Major Product Offerings
  7.2.4 Merck Covid-19 Treatments Revenue in Global (2016-2021)
  7.2.5 Merck Key News
7.3 Eli Lilly and Company
  7.3.1 Eli Lilly and Company Corporate Summary
  7.3.2 Eli Lilly and Company Business Overview
  7.3.3 Eli Lilly and Company Covid-19 Treatments Major Product Offerings
  7.3.4 Eli Lilly and Company Covid-19 Treatments Revenue in Global (2016-2021)
  7.3.5 Eli Lilly and Company Key News
7.4 Regeneron Pharmaceuticals
  7.4.1 Regeneron Pharmaceuticals Corporate Summary
  7.4.2 Regeneron Pharmaceuticals Business Overview
  7.4.3 Regeneron Pharmaceuticals Covid-19 Treatments Major Product Offerings
  7.4.4 Regeneron Pharmaceuticals Covid-19 Treatments Revenue in Global (2016-2021)
  7.4.5 Regeneron Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Covid-19 Treatments Market Opportunities & Trends in Global Market
Table 2. Covid-19 Treatments Market Drivers in Global Market
Table 3. Covid-19 Treatments Market Restraints in Global Market
Table 4. Key Players of Covid-19 Treatments in Global Market
Table 5. Top Covid-19 Treatments Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Covid-19 Treatments Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Covid-19 Treatments Revenue Share by Companies, 2016-2021
Table 8. Global Companies Covid-19 Treatments Product Type
Table 9. List of Global Tier 1 Covid-19 Treatments Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Covid-19 Treatments Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Covid-19 Treatments Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Covid-19 Treatments Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Covid-19 Treatments Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Covid-19 Treatments Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Covid-19 Treatments Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Covid-19 Treatments Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Covid-19 Treatments Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Covid-19 Treatments Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Covid-19 Treatments Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Covid-19 Treatments Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Covid-19 Treatments Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Covid-19 Treatments Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Covid-19 Treatments Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Covid-19 Treatments Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Covid-19 Treatments Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Covid-19 Treatments Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Covid-19 Treatments Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Covid-19 Treatments Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Covid-19 Treatments Revenue, (US$, Mn), 2022-2027
Table 30. Gilead Sciences Corporate Summary
Table 31. Gilead Sciences Covid-19 Treatments Product Offerings
Table 32. Gilead Sciences Covid-19 Treatments Revenue (US$, Mn), (2016-2021)
Table 33. Merck Corporate Summary
Table 34. Merck Covid-19 Treatments Product Offerings
Table 35. Merck Covid-19 Treatments Revenue (US$, Mn), (2016-2021)
Table 36. Eli Lilly and Company Corporate Summary
Table 37. Eli Lilly and Company Covid-19 Treatments Product Offerings
Table 38. Eli Lilly and Company Covid-19 Treatments Revenue (US$, Mn), (2016-2021)
Table 39. Regeneron Pharmaceuticals Corporate Summary
Table 40. Regeneron Pharmaceuticals Covid-19 Treatments Product Offerings
Table 41. Regeneron Pharmaceuticals Covid-19 Treatments Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Covid-19 Treatments Segment by Type
Figure 2. Covid-19 Treatments Segment by Application
Figure 3. Global Covid-19 Treatments Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Covid-19 Treatments Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Covid-19 Treatments Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Covid-19 Treatments Revenue in 2020
Figure 8. By Type - Global Covid-19 Treatments Revenue Market Share, 2016-2027
Figure 9. By Application - Global Covid-19 Treatments Revenue Market Share, 2016-2027
Figure 10. By Region - Global Covid-19 Treatments Revenue Market Share, 2016-2027
Figure 11. By Country - North America Covid-19 Treatments Revenue Market Share, 2016-2027
Figure 12. US Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Covid-19 Treatments Revenue Market Share, 2016-2027
Figure 16. Germany Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 17. France Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Covid-19 Treatments Revenue Market Share, 2016-2027
Figure 24. China Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 28. India Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Covid-19 Treatments Revenue Market Share, 2016-2027
Figure 30. Brazil Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Covid-19 Treatments Revenue Market Share, 2016-2027
Figure 33. Turkey Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Covid-19 Treatments Revenue, (US$, Mn), 2016-2027
Figure 37. Gilead Sciences Covid-19 Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Merck Covid-19 Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Eli Lilly and Company Covid-19 Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Regeneron Pharmaceuticals Covid-19 Treatments Revenue Year Over Year Growth (US$, Mn) & (2016-2021)